Skip to main content


Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease

Fig. 4

Association of CSF Aβ42 with the change in CSF DHA. Baseline CSF Aβ42 was significantly associated with the change in CSF DHA after supplementation (r = 0.37, p = 0.05). The change in DHA was calculated as the difference between 18-month CSF DHA levels and the levels at baseline. The correlation was obtained using Spearman’s correlation test. Aβ42 amyloid-β42, CSF cerebrospinal fluid, DHA docosahexaenoic acid

Back to article page